Daratumumab for autoimmune diseases: a systematic review

ObjectiveRefractory autoimmune diseases remain a significant challenge in clinical practice and new therapeutic options are needed. This systematic review evaluates the existing reported data on the CD38-targeting antibody daratumumab as a new therapeutic approach in autoantibody-mediated autoimmune...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatic & musculoskeletal diseases open 2023-12, Vol.9 (4), p.e003604
Main Authors: Holzer, Marie-Therese, Ruffer, Nikolas, Huber, Tobias B., Kötter, Ina, Ostendorf, Lennard, Krusche, Martin
Format: Article
Language:English
Subjects:
Anemia
Antibodies
Antibodies, Monoclonal - adverse effects
Autoantibodies
Autoimmune Diseases
Autoimmune Diseases - chemically induced
Autoimmune Diseases - drug therapy
Autoimmunity
Case reports
Cytotoxicity
Disease
Hematology
Humans
Immunotherapy
Lupus
Monoclonal antibodies
Multiple myeloma
Nephrology
Patients
Plasma
Proteins
Purpura
Remission (Medicine)
Rheumatology
Rituximab
Systematic review
Therapeutics
Treatments
Ventilation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!